Tag: U.K.
-
FDA Blocks Monthly HIV Drug Combo
The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV.
-
Psychedelic Depression Drug Tested for Safety
Results from an early clinical trial testing an hallucinogenic drug to treat depression shows the therapy is largely safe and feasible to administer.
-
Semiconductors Developed to Emulate Nerve Cells
Physicists and neuroscientists created semiconductors that in lab simulations and tests with animal models perform like nerve cells for biological functions.
-
Medical Knowledge A.I. Company Raises Early $4.8M
A company developing a system with artificial intelligence to analyze medical literature for treatment insights is raising nearly $5 million in its first venture round.
-
Consortium to Advance A.I. in Longevity Research
A group of academic, foundation, and business organizations are collaborating on the use of artificial intelligence in research on extending life spans.
-
Infographic – Q3 A.I. Health Investments Set Record
Venture capital funding for companies worldwide building artificial intelligence solutions in health care set new highs in the third quarter of 2019.
-
AstraZeneca Joins $1B Fund, Expands Footprint in China
The pharmaceutical company AstraZeneca is starting a joint $1 billion health care investment fund in China and vastly increasing its labs and offices there.
-
Touch Senses Added to Synthetic Skin, Robot Arm
Computer scientists in the U.K. and France created techniques for adding a refined sense of touch to highly sensitive artificial skin and an inexpensive robotic arm.
-
Trial to Test CBD for Parkinson’s-Related Psychosis
A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease.
-
Nanoparticles Designed to Cross Blood-Brain Barrier
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain.